Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The iLux and Mechanical Meibomian Gland Expression for the Treatment of Moderate and Severe Meibomian Gland Dysfunction.

NCT06278584 is registered in ClinicalTrials.gov with Clínica de Oftalmología de Cali S.A as lead sponsor.

NCT NCT06278584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The iLux and Mechanical Meibomian Gland Expression for the Treatment of Moderate and Severe Meibomian Gland Dysfunction.
Lead sponsor
Clínica de Oftalmología de Cali S.A
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
February 28, 2022
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eyes dry chronic, meibomian gland dysfunction